Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 1:32 pm Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Eventide Asset Management, LLC | 3,150,000 6.600% |
3,150,000 (New Position) |
Filing History |
| 2023-02-14 09:36 am Sale |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 3,150,000 6.300% |
-85,000 (-2.63%) |
Filing History |
| 2023-02-13 10:11 am Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,971,660 9.990% |
2,332,885 (+88.41%) |
Filing History |
| 2022-11-14 5:11 pm Purchase |
2022-11-10 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 3,398,661 7.100% |
3,398,661 (New Position) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
BLACKROCK INC BLK |
941,311 2.500% |
-2,075,578 (-68.80%) |
Filing History |
| 2022-02-14 4:31 pm Sale |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Lion Point Capital LP | 3,629,622 9.870% |
-939,312 (-20.56%) |
Filing History |
| 2022-02-14 4:28 pm Sale |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Boxer Capital LLC | 0 0.000% |
-1,200,000 (Position Closed) |
Filing History |
| 2022-02-14 4:18 pm Purchase |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Venrock Healthcare Capital Partners II, L.P. | 2,880,096 7.800% |
291,155 (+11.25%) |
Filing History |
| 2022-02-11 6:39 pm Purchase |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
683 Capital Management, LLC | 1,932,829 5.300% |
111,680 (+6.13%) |
Filing History |
| 2022-02-11 5:25 pm Purchase |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,638,775 7.200% |
586,417 (+28.57%) |
Filing History |
| 2022-02-11 10:01 am Purchase |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 3,235,000 8.800% |
2,858 (+0.09%) |
Filing History |
| 2022-02-02 7:18 pm Purchase |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
BLACKROCK INC BLK |
3,016,889 8.200% |
936,798 (+45.04%) |
Filing History |
| 2021-08-20 4:36 pm Purchase |
2021-08-10 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,052,358 5.600% |
2,052,358 (New Position) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Venrock Healthcare Capital Partners II, L.P. | 2,588,941 7.300% |
963,231 (+59.25%) |
Filing History |
| 2021-02-16 3:28 pm Sale |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
BCLS I Investco, LP | 1,298,178 3.600% |
-49,553 (-3.68%) |
Filing History |
| 2021-02-12 3:55 pm Purchase |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Lion Point Capital LP | 4,568,934 12.200% |
2,975,249 (+186.69%) |
Filing History |
| 2021-02-12 08:14 am Purchase |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 3,232,142 9.090% |
3,232,142 (New Position) |
Filing History |
| 2021-02-11 08:16 am Purchase |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
ADAGE CAPITAL PARTNERS GP LLC | 1,462,500 4.110% |
1,462,500 (New Position) |
Filing History |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
BLACKROCK INC BLK |
2,080,091 5.800% |
2,080,091 (New Position) |
Filing History |
| 2021-01-11 5:00 pm Purchase |
2020-12-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
683 Capital Management, LLC | 1,821,149 5.100% |
1,821,149 (New Position) |
Filing History |